CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 500 shares at $1.79 ($893)
- 4 Grant or award President and CEO acquired 11,606 shares (grant or award)
- 4 Grant or award President and CEO acquired 12,042 shares (grant or award)
- 5 Insider Annual Insider Trading Report
- 4 Grant or award President and CEO acquired 9,880 shares (grant or award)
- 4 Grant or award President and CEO acquired 10,303 shares (grant or award)
- 4 Grant or award President and CEO acquired 9,444 shares (grant or award)
- 4/A Grant or award President and CEO acquired 9,585 shares (grant or award)
- 4 Grant or award President and CEO acquired 10,035 shares (grant or award)
- 4 Grant or award President and CEO acquired 10,035 shares (grant or award)
- 4 Exercise or conversion Director acquired 2,236,204 shares (option exercise)
- 4 Grant or award President and CEO acquired 10,947 shares (grant or award)
Page 6 of 39 · 776 filings